Difference between revisions of "Baker Pharmaceuticals"
Sarna News
m (→Overview: hyphen) |
m |
||
| Line 1: | Line 1: | ||
| + | {{InfoBoxCorporation | ||
| + | | image = | ||
| + | | Founded = | ||
| + | | Dissolved = | ||
| + | | Previous Names = | ||
| + | | headquarters = New Benner ([[Baker 3]])<ref name=HSTLC-144/> | ||
| + | | leadership = [[CEO of Baker Pharmaceuticals|CEO]] | ||
| + | | products = | ||
| + | | Parent Corporation = | ||
| + | | Division = | ||
| + | }} | ||
'''Baker Pharmaceuticals''' was a pharmaceutical company in the [[Lyran Commonwealth]], with its assets eventually acquired by the mammoth [[Nashan Diversified]]. <ref name=HSTLC-144>''House Steiner (The Lyran Commonwealth)'', p. 144 "Socioeconomics - Other Major Commonwealth Industries - Baker Pharmaceuticals"</ref> <ref name=HHS-134>''Handbook: House Steiner'', p. 134 - "Economics - Major Industries- Nashan Diversified".</ref> | '''Baker Pharmaceuticals''' was a pharmaceutical company in the [[Lyran Commonwealth]], with its assets eventually acquired by the mammoth [[Nashan Diversified]]. <ref name=HSTLC-144>''House Steiner (The Lyran Commonwealth)'', p. 144 "Socioeconomics - Other Major Commonwealth Industries - Baker Pharmaceuticals"</ref> <ref name=HHS-134>''Handbook: House Steiner'', p. 134 - "Economics - Major Industries- Nashan Diversified".</ref> | ||
| Line 5: | Line 16: | ||
'''Commonwealth Stock Exchange Symbol:''' BakPhar. <ref name=HSTLC-144/> | '''Commonwealth Stock Exchange Symbol:''' BakPhar. <ref name=HSTLC-144/> | ||
| − | '''Home Office:''' | + | '''Home Office:''' |
'''President/CEO:''' John Sleeth (circa 3024).<ref name=HSTLC-144/> | '''President/CEO:''' John Sleeth (circa 3024).<ref name=HSTLC-144/> | ||
Revision as of 20:28, 28 April 2023
Baker Pharmaceuticals | |
|---|---|
| Corporation Profile | |
| Headquarters | New Benner (Baker 3)[1] |
| Leadership | CEO |
Baker Pharmaceuticals was a pharmaceutical company in the Lyran Commonwealth, with its assets eventually acquired by the mammoth Nashan Diversified. [1] [2]
Company Profile
Commonwealth Stock Exchange Symbol: BakPhar. [1]
Home Office:
President/CEO: John Sleeth (circa 3024).[1]
Overview
Baker Pharmaceuticals had been in business with the Lyran Commonwealth for many years but encountered serious financial and personnel problems after losing a 300-million-S-Bill lawsuit in 3023 when a batch of their synthetic molecular antibodies went toxic, killing over 100 Lyran Commonwealth Armed Forces soldiers. Like a shark smelling blood in the water, Nashan Diversified launched a takeover attempt in 3024, which Baker CEO John Sleeth attempted to resist by ordering his brokers to buy back all public Baker stocks at a substantially higher price than Nashan's offer.[1]
While saving the company in the short-term, the heavy financial burden of the buy-back forced BP to cut costs and let go staff, leaving it in dire straits with many observers questioning if the company would survive beyond 3025.[1] Nashan would ultimately succeed in acquiring Baker Pharmaceuticals, but rather than reorganize and integrate the company's Baker 3 headquarters into the Nashan family, Nashan chose to virtually liquidate BP and transfer its remaining assets to Nashan's newer Donegal offices to serve as its Nashan Pharmaceuticals division.[2]